Guideline Summary: Evaluation and Management of Hematuria

Classification of Hematuria

• Gross (macroscopic) hematuria carries a 30–40 % risk of underlying malignancy and therefore mandates urgent urologic evaluation, even when self‑limited. 1
• Microscopic hematuria is defined as ≥ 3 red blood cells per high‑power field (RBC/HPF) on properly collected urine specimens. 1
• Dipstick testing has a 65–99 % specificity and is prone to false‑positives from myoglobin, hemoglobin, menstrual blood, or dietary substances; microscopic confirmation is required before any further work‑up. 1

Risk Factors for Urologic Malignancy

• Age > 35–40 years, smoking > 30 pack‑years, occupational exposure to benzenes or aromatic amines, prior gross hematuria, and irritative voiding symptoms without infection increase the likelihood of bladder or upper‑tract cancer. 1

Common Non‑Glomerular Causes

Urologic (Non‑Glomerular)

• Urinary calculi are a frequent cause of both microscopic and macroscopic hematuria, often presenting with flank pain. 3
• Urinary‑tract infection typically produces hematuria that resolves after appropriate antibiotics; persistent hematuria > 6 weeks after treatment warrants full urologic evaluation. 3
• Benign prostatic hyperplasia can cause hematuria in older men but does not exclude concurrent malignancy; gross hematuria must still be investigated. 1
• Trauma to the kidneys or lower urinary tract leads to macroscopic hematuria; contrast‑enhanced CT is required to assess injury extent. 3

Metabolic / Anatomic

• Hypercalciuria and hyperuricosuria may produce microscopic hematuria and mild proteinuria; a spot urine calcium‑to‑creatinine ratio is the preferred initial test. 1
• Nutcracker syndrome (left renal vein compression) causes hematuria with variable proteinuria and is diagnosed by Doppler ultrasound. 1

Systemic / Other

• Vigorous exercise can cause transient hematuria that resolves after cessation of activity. 1
• Menstrual contamination can produce false‑positive urine results; a catheterized specimen is recommended when clean‑catch is unreliable. 1
• Anticoagulants and antiplatelet agents do not cause hematuria but may unmask underlying pathology; evaluation must proceed regardless of their use. 1
• Coagulopathies (e.g., hemophilia) and sickle‑cell disease can lead to hematuria via bleeding disorders or papillary necrosis. 3

Glomerular Causes and Indicators

• Post‑infectious glomerulonephritis and IgA nephropathy are common glomerular sources of hematuria. 3
• Tea‑ or cola‑colored urine, proteinuria > 2 + on dipstick, > 80 % dysmorphic RBCs, and red‑blood‑cell casts strongly suggest a glomerular origin. 3
• Alport syndrome presents with hereditary nephritis, hearing loss, and ocular abnormalities; audiogram and slit‑lamp examination are indicated when suspected. 3
• Thin basement membrane nephropathy is the most frequent cause of benign familial hematuria; screening first‑degree relatives’ urine is useful. 1
• Lupus nephritis, vasculitis, and interstitial renal disease (including drug‑induced) can also produce hematuria. 3

Diagnostic Confirmation of True Hematuria

• Confirm hematuria with microscopic urinalysis showing ≥ 3 RBC/HPF on at least two of three properly collected specimens before initiating further evaluation. 1
• Exclude pseudo‑hematuria (myoglobinuria, hemoglobinuria, menstrual contamination, food or medication pigments) using appropriate laboratory differentiation. 3

Stepwise Work‑up Algorithm

Exclude Transient Benign Causes

• Rule out recent vigorous exercise, sexual activity, viral illness, trauma, or menstruation; repeat urinalysis 48 h after the suspected trigger. 1

Distinguish Glomerular vs. Non‑Glomerular Sources

• Glomerular indicators: > 80 % dysmorphic RBCs or RBC casts; proteinuria > 0.5 g/g (or > 500 mg/24 h); elevated serum creatinine; hypertension; tea‑colored urine. 1
• Non‑glomerular indicators: > 80 % isomorphic RBCs with minimal or no proteinuria; absence of dysmorphic RBCs, casts, or significant proteinuria. 1

Risk Stratification for Urologic Malignancy

Imaging Recommendations

• Multiphasic CT urography (unenhanced, nephrographic, excretory phases) is the preferred upper‑tract imaging modality, offering ≈ 96 % sensitivity and ≈ 99 % specificity for renal cell carcinoma, transitional cell carcinoma, and stones. 1
• When CT is contraindicated, MR urography or renal ultrasound with retrograde pyelography are acceptable alternatives. 1

Cystoscopy and Urine Cytology

• Flexible cystoscopy is mandatory for all patients with gross hematuria and for microscopic hematuria in individuals ≥ 40 years or with high‑risk features; it provides direct visualization of the bladder, urethra, and ureteral orifices. 1
• Flexible cystoscopy is preferred over rigid cystoscopy due to lower pain with equivalent diagnostic accuracy. 1
• Voided urine cytology should be obtained in high‑risk patients (age > 60 yr, smoking > 30 pack‑years, occupational exposures) to detect high‑grade urothelial carcinoma and carcinoma in situ. 1

Laboratory Evaluation

Follow‑up and Monitoring

• If the initial work‑up is negative but hematuria persists, repeat urinalysis at 6, 12, 24, and 36 months with blood‑pressure measurement at each visit. 1
• After two consecutive negative annual urinalyses, further testing is unnecessary. 1
• Immediate re‑evaluation is required for new gross hematuria, a marked increase in microscopic hematuria, emergence of urologic symptoms, hypertension, proteinuria, or evidence of glomerular bleeding. 1

Age‑Specific Considerations

Children

• Isolated microscopic hematuria without proteinuria or dysmorphic RBCs is unlikely to represent significant renal disease; imaging is not required. 3
• Renal ultrasound is the preferred initial imaging to assess kidney anatomy, size, and position before any potential biopsy. 3
• Gross hematuria in children warrants renal and bladder ultrasound to exclude nephrolithiasis, anatomic anomalies, or rare tumors. 1

Adults (≥ 35–40 years)

• Due to the substantial malignancy risk, cystoscopy and CT urography are recommended for all patients with gross hematuria and most with microscopic hematuria. 1

Elderly

• Males ≥ 60 years are automatically classified as high‑risk and require both cystoscopy and CT urography regardless of other factors. 1
• Females ≥ 60 years with any additional risk factor (e.g., smoking, gross hematuria, > 25 RBC/HPF) also need full urologic evaluation. 1